GSK plcGSKNYSE
Loading
Year-over-year net income growth rate
| Period | Value |
|---|---|
| Q4 2025 | -68.82% |
| Q4 2025 | 39.50% |
| Q2 2025 | -11.15% |
| Q1 2025 | 292.27% |
| Q4 2024 | 813.79% |
| Q3 2024 | -104.94% |
| Q2 2024 | 12.14% |
| Q1 2024 | 198.86% |
| Q4 2023 | -76.09% |
| Q3 2023 | -9.85% |
| Q2 2023 | 8.99% |
| Q1 2023 | 1.98% |
| Q4 2022 | -86.50% |
| Q3 2022 | 1191.29% |
| Q2 2022 | -53.50% |
| Q1 2022 | 140.59% |
| Q4 2021 | -45.25% |
| Q3 2021 | -1.94% |
| Q2 2021 | 30.01% |
| Q1 2021 | 58.49% |
| Q4 2020 | -45.58% |
| Q3 2020 | -45.03% |
| Q2 2020 | 44.60% |
| Q1 2020 | 20.48% |
| Q4 2019 | -16.30% |
| Q3 2019 | 61.00% |
| Q2 2019 | 16.14% |
| Q1 2019 | -31.69% |
| Q4 2018 | -14.32% |
| Q3 2018 | 221.54% |
| Q2 2018 | -19.67% |
| Q1 2018 | 200.55% |
| Q4 2017 | -145.05% |
| Q3 2017 | 773.33% |
| Q2 2017 | -117.21% |
| Q1 2017 | 307.00% |
| Q4 2016 | -68.19% |
| Q3 2016 | 285.75% |
| Q2 2016 | -254.26% |
| Q1 2016 | 179.66% |